Magnetic Insight Signs Supply Agreement with Meito Sangyo Co Ltd to Enable Cell Therapy Research with Magnetic Particle Imaging

ALAMEDA, CA May 25, 2016 – Magnetic Insight Inc, a developer of innovative imaging technologies for quantitative angiography and non-invasive cell tracking in research and the clinic, announced today that they have entered into a strategic supply agreement with Meito Sangyo, global provider of chemicals and enzymes in research, diagnostics, food processing and cosmetics. In the agreement, Magnetic Insight will develop and market VivoTrax, a superparamagnetic iron oxide nanoparticle coated with carboxydextran, as a tracer to support stem cell and immune cell tracking in research for both magnetic particle imaging (MPI) and magnetic resonance imaging applications. The VivoTrax cell tracking kit utilizes Meito Sangyo’s Ferucarbotran product, a well-established precursor iron oxide material with translational uses in the clinic.

Read more…

Magnetic Insight to Collaborate with Stanford School of Medicine on Magnetic Particle Imaging to Advance Cancer Research and Neurovascular Imaging.

NEWARK, California, USA March 10, 2016 – Magnetic Insight Inc, a developer of innovative diagnostic imaging technologies, announced today a collaboration with the Stanford School of Medicine around magnetic particle imaging for solving challenges in cell therapy and vascular imaging with magnetic particle imaging. Christopher Contag, PhD, professor of pediatrics, radiology, bioengineering and of microbiology & immunology, will lead an effort to better understand early disease states in cancer and new therapeutic paths. Max Wintermark MD, professor of radiology and chief of neuroradiology at Stanford Health Care will also utilize the new imaging technology to perform quantitative cerebral perfusion and vascular studies in a variety of disease states, including stroke, traumatic brain injury, brain cancer, with the goal to eventually improve diagnosis and care in patients affected with these conditions.

Read more…

Magnetic Insight Secures Seed Funding to Accelerate Development of Magnetic Particle Imaging Technology

Medical imaging startup raises the bar in imaging safety and sensitivity by harnessing a unique nanoparticle detection technology, transforming preclinical research and development with direct translation to clinical imaging diagnostics.

NEWARK, California, USA April 15, 2015 – Magnetic Insight Inc., a developer of innovative imaging technologies for quantitative angiography and non-invasive cell tracking in research and the clinic, announced today that the company has secured an undisclosed amount in seed funding from a prominent life science investor, and an SBIR technology award.

Read more…

Magnetic Insight Has Been Selected to Join the StartX Group

February 28, 2015 – Magnetic Insight has been selected to join the StartX group, a leading entrepreneurial program with an incredible legacy of developing start-ups in becoming high impact and valued companies.

StartX Med logo

Magnetic Insight Will Join the Spring 2015 BayBio FAST Advisory Program

February 23, 2015 – Magnetic Insight will be joining the Spring 2015 BayBio FAST Advisory program. BayBio FAST program selects the most promising young Bay Area life science companies and helps fast-track their way to funding and success by drawing on the vast and rich experience of Northern California’s vibrant life science community.

BayBio logo